HeyJaredLiam Andrew Davenport
- Indexed articles, last 90 days
- 34
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Cancer Therapy Advisor
- Top 5M sites
- Earliest in this view
- Jul 8, 2026
Latest articles
Cancer Mortality Continues to Decline Due to Ongoing Lung Cancer Progress - Oncology Nurse Advisor (opens the original)
Read excerpt
Although the overall incidence of cancer has either risen slightly or remained stable in recent years, cancer mortality has decreased steadily, according to an annual report published in Cancer. This decrease in mortality is partly due to substantial progress in lung cancer outcomes accompanied by reduced tobacco exposure and earlier detection, researchers noted. In this analysis, the researchers drew on the North American Association of Central Cancer Registries database to obtain information o
Cancer Mortality Continues to Decline Due to Ongoing Lung Cancer Progress (opens the original)
Read excerpt
Although the overall incidence of cancer has either risen slightly or remained stable in recent years, cancer mortality has decreased steadily, according to an annual report published in Cancer. This decrease in mortality is partly due to substantial progress in lung cancer outcomes accompanied by reduced tobacco exposure and earlier detection, researchers noted. In this analysis, the researchers drew on the North American Association of Central Cancer Registries database to obtain information o
Oncology Clinical Trial Enrollment Is Affected by Sociodemographic Disparities (opens the original)
Read excerpt
Enrollment of patients with invasive cancer to clinical trials follows established lines of sociodemographic disparities even in integrated health systems with designated community oncology programs, according to research published by JAMA Network Open. Disparities were found on the basis of age, socioeconomic status, and language spoken, among other patient characteristics, study researchers reported. For this retrospective study, the researchers examined demographic and clinical characteristic
Use of Neoadjuvant Chemo Does Not Affect 10-Year Survival in Advanced Ovarian Cancer (opens the original)
Read excerpt
The use of neoadjuvant chemotherapy (NACT) does not worsen 10-year survival compared to primary debulking surgery in patients with advanced epithelial ovarian cancer, according to research published in JAMA Network Open.1 After the 2010 publication of a landmark randomized controlled trial (RCT) that demonstrated the noninferiority of NACT compared to primary debulking surgery, “US cancer programs varied considerably in adopting this strategy,” study researchers explained.1,2 In this study, the
Prostate Cancer Health Care Spending Has More Than Tripled in 10 Years (opens the original)
Read excerpt
Total expenditure on prostate cancer-related health care has increased sharply in the US over a 10-year period, according to research published in JAMA Network Open. Systemic therapy, principally second-generation androgen deprivation therapy (ADT), appears to be the main driver of the increase, study researchers reported. For this economic analysis, the researchers drew on Surveillance, Epidemiology, and End Results-Medicare linked data from January 1, 2012, to December 31, 2021. They integrate
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Cancer Therapy Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.